FRANK SAVORETTI: Open Payments
NPI 1750377149 · JOHNSTON, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 34 payments from 12 companies in 2025. Trend: 2023 $84 · 2024 $577 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $160 |
| GlaxoSmithKline, LLC. | 13 | $157 |
| Lilly USA, LLC | 2 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Exact Sciences Corporation | 2 | $47 |
| Inspire Medical Systems, Inc. | 2 | $38 |
| Amgen Inc. | 2 | $34 |
| PFIZER INC. | 1 | $18 |
| ABBVIE INC. | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
Products named: TRELEGY ELLIPTA, JARDIANCE, AIRSUPRA, FARXIGA, INSPIRE, The Cologuard Plus Collection Kit, Cologuard Collection Kit, PAXLOVID.
Industry payments across RI — which companies pay providers there.
